Skip to content

Product Development Study of the GluCath Intravascular Continuous Glucose Monitoring System (GluCath System).

Product Development Study of the GluCath Intravascular Continuous Glucose Monitoring System (GluCath System). - PRECISE Trial (GluCath System)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36217
Enrollment
20
Registered
2011-11-08
Start date
2012-05-08
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age * 18 years; Expected to be admitted to the ICU after elective cardiac surgery and expected to require glycemic control; Expected to have a radial arterial catheter placed for invasive pressure monitoring or frequent arterial blood sampling; Willing to have one GluCath sensor inserted by a health care professional through a standard radial artery catheter inserted either preoperatively or within six hours after admission to the ICU to provide routine care; Willing to permit hourly arterial blood samples;

Exclusion criteria

Exclusion criteria: An expected ICU stay of

Design outcomes

Primary

MeasureTime frame
Main study parameters will include reference analyzer blood glucose values, GluCath System glucose values and duration of sensor use. Difference statistics will include mean difference, standard deviation of the differences, mean relative difference, and mean absolute relative difference, stratified by glucose ranges.

Secondary

MeasureTime frame
Additional analyses will include the percentage of points compliant with current and proposed accuracy standards (ISO 15197 and TNO Glucose Meters Quality Standards) stratified by glucose ranges, Modified Bland-Altman plot analysis and Clarke Error Grid analysis.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)